HealthUnlockedHealthUnlocked
AboutLog in

Experiences with

Atazanavir / Cobicistat

  • Posts

  • Communities

2 public posts

Gilead Announces Phase 3 Results for Genvoya® (Elvitegravir, Cobicistat, etc.), an Investigational Once-Daily Single Tablet Regimen for HIV

http://www.natap.org/2015/EACS/EACS_01.htm
http://www.natap.org/2015/EACS/EACS_01.htm
kcohen profile image
kcohen
in HFI Connect - Hepatitis

FDA Approves Two Combination Therapies for HIV

Evotaz by Bristol-Myers Squibb is a combination of 300 mg atazanavir (Reyataz, Bristol-Myers Squibb) and 150 mg cobicistat (a pharmacokinetic enhancer by Gilead Sciences), which should be used with other antiretroviral agents. Evotaz should be dosed once a day. Read more http://bit.ly/1yga8lR
Evotaz by Bristol-Myers Squibb is a combination of 300 mg atazanavir (Reyataz, Bristol-Myers Squibb) and 150 mg cobicistat (a pharmacokinetic enhancer by Gilead Sciences), which should be used with other antiretroviral agents. Evotaz should be dosed once a day. Read more http://bit.ly/1yga8lR
mwright profile image
mwright
in HFI Connect - Hepatitis
Want to take advantage of all our features? Just log in!
or
    Filter results
    Posted in
    Sort by
    HealthUnlocked
    © 2022 All rights reserved.

    Company

    About Us

    Our Team

    Partner with us

    Careers

    Product

    Health terms A to Z

    Communities A to Z

    Start a Community

    Support

    Help Centre

    Community Guidelines

    Contact us

    Cookies settings